Major Biotech, Pharma and FDA Catalysts Coming in October
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
All Work
Chris Lange
Why This Analyst Thinks Tesla Isn’t the Top Pick for Autonomous Vehicles
The autonomous vehicle industry is currently a main focus of the tech industry. Most of the major players have plans to take some piece of this market.
PQ Group Quietly Enters the Market in IPO
PQ Group quietly entered the market on Friday as one of the largest initial public offerings this quarter.
Why One Analyst Sees Another 50% Upside at Conn’s
Conn’s shares made a handy gain on Friday after one analyst changed its tune on the electronics store.
Why Zogenix Shares More Than Doubled
Zogenix saw its shares more than double early on Friday after the company reported positive top-line results from its most recent late-stage trial in the treatment of Dravet syndrome.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a relatively mixed day for the U.S. broad markets. Although all the major averages started off negative a couple actually turned a gain on the day. Crude oil gave some back today…
AbbVie and Amgen Reach Global Resolution of Humira
AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes with Amgen.
Roku Enters the Market With a Bang
Roku entered the market with a bang on Thursday morning as one of the most anticipated initial public offerings this fall.
Angry Birds Maker Rovio Prices IPO
Rovio Entertainment, the maker of the wildly successful mobile game Angry Birds, has announced the pricing for its initial public offering.
Why Rite Aid Hit a New Multiyear Low
Rite Aid watched its shares hit a multiyear low on Thursday after the company reported its most recent quarterly results.
BlackBerry Continues to Rally Despite Mixed Q2 Results
BlackBerry released mixed fiscal second-quarter financial results before the markets opened Thursday.
Zynerba Pharma Wins Big on Cannabis Trial
Zynerba Pharmaceuticals shares saw a huge gain early on Thursday after the firm announced positive results from its mid-stage cannabinoid trial.
Wednesday’s Biggest Winners & Losers in the S&P 500
Wednesday was a positive day for the broad markets, seemingly making up for short comings earlier this week. Crude oil bounced back after taking a step back on Tuesday. The best performing sector in…
What to Expect When BlackBerry Reports Q2 Earnings
BlackBerry is scheduled to release its most recent quarterly results before the markets open on Thursday. Here is what to expect.
Nike Trampled After Q1 Earnings Report
After Nike reported its quarterly results late on Tuesday, the investor reaction Wednesday practically wiped out all of its gains so far this year. It doesn't seem like the sports apparel field is getting…
Short Sellers Can’t Make Up Their Minds on Cybersecurity Stocks
The September 15 short interest data have been compared with the previous figures, and short interest moves in these selected cybersecurity stocks were mixed.
Social Media Short Sellers Grow More Selective
The September 15 short interest data have been compared with the previous report. Short interest in these selected social media stocks was mixed for this settlement date.
Short Sellers Hike Bets in Major Biotechs
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
Short Sellers Chase Major Oil Stocks Higher
The September 15 short interest data have been compared with the previous figures, and short interest for most of the selected oil stocks increased.
Tech Rally Pushes Major Semiconductor Short Interest Even Higher
The September 15 short interest data have been compared with the previous report. Short interest increased in all these selected semiconductor stocks.